As we mentioned, several researches on PPARγ2 Pro12Ala polymorphism have indicated this polymorphism is pathogenic in different diseases including T2DM, insulin sensitivity, obesity, cardiovascular diseases, Alzheimer's disease, and cancer [3]. This evidence concerns the gene PPARG and type 2 diabetes mellitus.